Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Mallinckrodt
Deloitte
Boehringer Ingelheim
Baxter
Farmers Insurance
McKesson
Johnson and Johnson

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,513,006

« Back to Dashboard

Summary for Patent: 4,513,006
Title: Anticonvulsant sulfamate derivatives
Abstract:Sulfamates of the following formula (I): ##STR1## wherein X is O or CH.sub.2 and R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as herein defined have been found to exhibit anticonvulsant activity and are thus useful in the treatment of conditions such as epilepsy. Further, pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention.
Inventor(s): Maryanoff; Bruce E. (New Hope, PA), Gardocki; Joseph F. (Doylestown, PA)
Assignee: McNeil Lab., Inc. (Fort Washington, PA)
Application Number:06/535,475
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,513,006
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,513,006

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,513,006

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland 843765 ➤ Try a Free Trial
Finland 79095 ➤ Try a Free Trial
European Patent Office 0138441 ➤ Try a Free Trial SPC/GB95/028 United Kingdom ➤ Try a Free Trial
European Patent Office 0138441 ➤ Try a Free Trial 97C0097 Belgium ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
Covington
AstraZeneca
Chubb
Harvard Business School
Merck
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.